Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Manufactures and develops pharmaceutical products

Shanghai Acrono Pharmaceutical Co., Ltd., established on 2005-04-22, Business scope includes technical development of pharmaceutical and biotechnology products,technology transfer,technical consulting,Technical Services,medicine(see license),Production of pharmaceutical raw materials,Sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Chemi SpA operates as a chemical pharmaceutical company. It focuses on the development, production and sales of generic active pharmaceutical ingredients, complex to make generics, and peptides. The firm offers pre-filled syringes, vials and oral tablets. The company was founded in 1973 is headquartered in Cinisello Balsamo, Italy.

Dezhou Deyao Pharmaceutical Co., Ltd., established on 2003-12-29, Business scope includes production and sales:Freeze-dried powder injection(Contains antineoplastic drugs),tablet,hard capsule,Granules,Pills,API(Cisplatin,Azithromycin Fumarate,caffeic acid,Esmolol Hydrochloride,Pemetrexed Disodium,Gemcitabine Hydrochloride).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Chongqing Pharmaceutical Research Institute Co., Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., is a Chinese company located in Chongqing. The firm manufactures pharmaceutical products.

Samyang Biopharmaceuticals Corp. wholesales medical supplies and other medicine-related products. The company was founded on November 1, 2011 and is headquartered in Seongnam, South Korea.

Chongqing Carelife Pharmaceutical Co., Ltd. is a pharmaceutical company in China. It engages in chemical materials, preparation, capsule, pelletized granule, injection, medical intermediate, Research & Development of Chinese and western medicines. The company was founded in 2000 and is headquartered in Chongqing, CN.

Shandong Boyuan Pharmaceutical Co., Ltd. is a Chinese company located in Jinan. The firm manufactures and wholesales pharmaceutical products. It was founded in 2005.

Hainan Jinrui Pharmaceutical Co., Ltd., established on 2008-04-07, The business scope includes freeze-dried powder injection,small volume injection,tablet,Capsules,Granules,pill,dry suspension,Powder,Production of raw materials,Sales,Sales of pharmaceutical packaging materials,drug development,technology transfer.(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China.

Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India.

Pudepharma is a pharmaceutical company. It also engages in the research and development, production, and sale of chemical drugs and medicine compound preparations. It produces pharmaceutical raw materials, raw materials and powder injections, water injection, oral solid preparation, traditional Chinese medicine extraction, and more.

Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which 60% comes from international operations. The group has an extensive geographic footprint with presence in 70 countries worldwide and more than 80% of export revenue coming from US, UK and EU. Intas operates over 10 manufacturing facilities worldwide. These facilities have regulatory approvals from multiple global agencies and enjoy an excellent reputation for quality and compliance. The group has capabilities to produce a wide variety of dosage forms including solid orals, liquids, lyophilized sterile preparations, creams, drops and injectables. Intas employs 12,000 people globally with over 400 located in Europe. The company employs over 800 scientists; spends approximately 6% of sales on R&D per annum and has been granted 27 international patents. In addition to generics formulation, R&D is focused on value added products such as biosimilars, value added and improved generics using novel drug delivery systems (NDDS) and innovative active pharmaceutical ingredients (API). Intas has the largest commercialised portfolio of biosimilars in India and is the first Indian pharmaceutical company to launch a biosimilar in the EU. Intas is privately held, based in Ahmedabad India, and backed by two leading financial investors, Temasek and ChrysCapital

Shanghai Golden Pharmaceutical Technology Development Co., Ltd., established on 2001-07-11, The scope of business includes engaging in technical services in the field of bioengineering,technical consulting,technology transfer,technology development,Development of Pharmaceutical Products,consult,to promote,acting;Sales of chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),hygiene products(Does not include drug sales),Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Wuhan Kanglan Pharmaceutical Co., Ltd., established on 2014-01-23, The business scope includes raw materials and pharmaceutical intermediates(Does not contain drugs)development,Research,Production,Sales;engaged in drug research,to develop,Technical consulting and technology transfer;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(In the above-mentioned scope of business, the projects with special provisions of the state shall be operated within the approved period after approval or with the license)